Crossmark

Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy

Crossref DOI link: https://doi.org/10.1038/nrc.2017.28

Published Online: 2017-05-24

Published Print: 2017-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

von Karstedt, Silvia

Montinaro, Antonella

Walczak, Henning
License Information

Text and Data Mining valid from 2017-05-24
More Information

Article History

First Online: 24 May 2017

Competing interests

: H.W. is a scientific adviser, co-founder and shareholder of Apogenix AG. The other authors declare no competing interests.